Gemini Pharmaceuticals, Inc.

Form 483FOIA Uncovered

Commack, New York, United StatesFEI 2432926Issued July 26, 2022

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 2432926.

Observations1

Issue DateJuly 26, 2022

StatusNo Warning Letter

Related Inspections10

Establishment Details

Firm: Gemini Pharmaceuticals, Inc.
Location: Commack, New York, United States
FEI Number: 2432926
Product Type: Drugs
Issue Date: July 26, 2022
Country: United States

Inspection History, 2009 to 2026

NAI4

VAI6

NAI means No Action Indicated. VAI means Voluntary Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Gemini Pharmaceuticals, Inc. FDA Form 483, Commack, New York, July 26, 2022